As this patient collection consisted of low stage HGS carcinomas, this finding lends further support to prior studies of early/low stage HGS, which showed somatic TP53 mutations in serous tubal intraepithelial carcinomas from women with germline mutations in BRCA1 or BRCA2 (38). This evidence concerns the gene BRCA2 and carcinoma.